5 Safe Stocks To Invest In For The Long-Term in 2023

3. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 88

Johnson & Johnson (NYSE:JNJ), founded in 1886, is a renowned American multinational corporation celebrated for its pioneering contributions in medical devices, pharmaceuticals, and consumer packaged goods. Remarkably, the pharmaceutical division of the company has maintained an impressive record of consistent dividend growth, extending over 62 years. At present, Johnson & Johnson (NYSE:JNJ) issues a quarterly dividend of $1.19 per share, resulting in a dividend yield of 3.14% as of October 24.

During Q2 2023, the number of hedge funds monitored by Insider Monkey that held positions in Johnson & Johnson (NYSE:JNJ) rose to 88, up from 86 in the previous quarter. The combined stakes held by these hedge funds exceed a total value of $4.1 billion. The primary hedge fund investor in Johnson & Johnson (NYSE:JNJ) is Ray Dalio’s Bridgewater Associates, possessing a significant stake valued at approximately $526.58 million.

Follow Johnson & Johnson (NYSE:JNJ)